- Home
- PMAX vs OCX Comparison
PMAX vs OCX Comparison
Compare PMAX & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMAX
- OCX
- Stock Information
- Founded
- PMAX 2019
- OCX 2009
- Country
- PMAX Hong Kong
- OCX United States
- Employees
- PMAX N/A
- OCX N/A
- Industry
- PMAX
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PMAX
- OCX Health Care
- Exchange
- PMAX Nasdaq
- OCX Nasdaq
- Market Cap
- PMAX 6.6M
- OCX 80.1M
- IPO Year
- PMAX 2024
- OCX N/A
- Fundamental
- Price
- PMAX $0.28
- OCX $3.87
- Analyst Decision
- PMAX
- OCX Buy
- Analyst Count
- PMAX 0
- OCX 3
- Target Price
- PMAX N/A
- OCX $4.42
- AVG Volume (30 Days)
- PMAX 7.7M
- OCX 120.1K
- Earning Date
- PMAX 03-25-2025
- OCX 04-11-2025
- Dividend Yield
- PMAX N/A
- OCX N/A
- EPS Growth
- PMAX N/A
- OCX N/A
- EPS
- PMAX 0.04
- OCX N/A
- Revenue
- PMAX $5,970,263.00
- OCX $709,000.00
- Revenue This Year
- PMAX N/A
- OCX N/A
- Revenue Next Year
- PMAX N/A
- OCX $106.34
- P/E Ratio
- PMAX $7.01
- OCX N/A
- Revenue Growth
- PMAX 30.05
- OCX N/A
- 52 Week Low
- PMAX $0.28
- OCX $1.92
- 52 Week High
- PMAX $4.70
- OCX $4.75
- Technical
- Relative Strength Index (RSI)
- PMAX N/A
- OCX 71.87
- Support Level
- PMAX N/A
- OCX $3.60
- Resistance Level
- PMAX N/A
- OCX $4.75
- Average True Range (ATR)
- PMAX 0.00
- OCX 0.47
- MACD
- PMAX 0.00
- OCX 0.10
- Stochastic Oscillator
- PMAX 0.00
- OCX 63.77
About PMAX Powell Max Limited Class A Ordinary Shares
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.